Dow Jones

39 118,86

-0,12%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
AMEX
Daxor Corporation (DXR)
Daxor Corporation (DXR) Actualités

DXR

Daxor (DXR)

Daxor Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:AMEX:DXR

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/06/2023	22h53	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	AMEX:DXR	Daxor Corporation
31/05/2023	18h54	Edgar (US Regulatory)	Notification of Late Filing of Monthly Portfolio Investments Report on Form N-port (public) (nt Nport-p)	AMEX:DXR	Daxor Corporation
26/05/2023	12h02	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:DXR	Daxor Corporation
16/03/2023	21h37	Edgar (US Regulatory)	Annual Report for Registered Investment Companies (n-cen)	AMEX:DXR	Daxor Corporation
01/03/2023	23h13	Edgar (US Regulatory)	Certified Annual Shareholder Report for Management Investment Companies (n-csr)	AMEX:DXR	Daxor Corporation
04/01/2023	21h45	Edgar (US Regulatory)	Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2/a)	AMEX:DXR	Daxor Corporation
06/12/2022	23h20	Edgar (US Regulatory)	Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2)	AMEX:DXR	Daxor Corporation
25/11/2022	17h17	Edgar (US Regulatory)	Monthly Portfolio Investments Report on Form N-port (public) (nport-p)	AMEX:DXR	Daxor Corporation
17/11/2022	15h01	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	AMEX:DXR	Daxor Corporation
14/11/2022	22h47	Edgar (US Regulatory)	Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a)	AMEX:DXR	Daxor Corporation
29/08/2022	21h47	Edgar (US Regulatory)	Annual Report of Proxy Voting Record for Management Investment Companies (n-px)	AMEX:DXR	Daxor Corporation
25/08/2022	22h07	Edgar (US Regulatory)	Certified Semi-annual Shareholder Report for Management Investment Companies (n-csrs)	AMEX:DXR	Daxor Corporation
01/02/2022	12h45	Edgar (US Regulatory)	Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)	AMEX:DXR	Daxor Corporation
01/02/2022	12h42	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	AMEX:DXR	Daxor Corporation
21/01/2022	14h00	GlobeNewswire Inc.	Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors	AMEX:DXR	Daxor Corporation
20/01/2022	22h05	GlobeNewswire Inc.	Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022	AMEX:DXR	Daxor Corporation
06/01/2022	14h00	GlobeNewswire Inc.	Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference	AMEX:DXR	Daxor Corporation
05/01/2022	14h00	GlobeNewswire Inc.	DAXOR ANNOUNCES KEY MILESTONES ACHIEVED FOR MULTICENTER BVA-100® STUDY IN HOSPITALIZED PATIENTS WITH COVID-19	AMEX:DXR	Daxor Corporation
04/01/2022	14h00	GlobeNewswire Inc.	DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES	AMEX:DXR	Daxor Corporation
16/11/2021	14h00	GlobeNewswire Inc.	Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting	AMEX:DXR	Daxor Corporation
09/11/2021	14h00	GlobeNewswire Inc.	New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®) Diagnostic in Neurocritical Care	AMEX:DXR	Daxor Corporation
01/10/2021	14h30	GlobeNewswire Inc.	Daxor Corporation Receives $200K Matching Fund Award from Launch Tennessee	AMEX:DXR	Daxor Corporation
15/09/2021	23h30	Edgar (US Regulatory)	Amendment to Annual Report for Registered Investment Companies (n-cen/a)	AMEX:DXR	Daxor Corporation
14/09/2021	14h30	GlobeNewswire Inc.	Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting	AMEX:DXR	Daxor Corporation
08/09/2021	14h30	GlobeNewswire Inc.	Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021	AMEX:DXR	Daxor Corporation
07/09/2021	14h30	GlobeNewswire Inc.	Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference	AMEX:DXR	Daxor Corporation
01/09/2021	14h30	GlobeNewswire Inc.	Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders	AMEX:DXR	Daxor Corporation
30/08/2021	14h30	GlobeNewswire Inc.	Daxor Corporation Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR Filing for the Six Months Ended June 30, 2021	AMEX:DXR	Daxor Corporation
04/08/2021	14h30	GlobeNewswire Inc.	Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care	AMEX:DXR	Daxor Corporation
22/07/2021	14h30	GlobeNewswire Inc.	DAXOR CORPORATION ANNOUNCES NON-GOVERNMENT DISTRIBUTION AGREEMENT WITH CONCORDANCE® HEALTHCARE SOLUTIONS	AMEX:DXR	Daxor Corporation